Temozolomide and Radiotherapy Versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial. Mircea S. Tesileanu , Marc Sanson , Wolfgang Wick , Alba A. Brandes , Paul M. Clement , Sara C. Erridge , Michael A. Vogelbaum , Anna K. Nowak , Jean-Francois Baurain , Warren P. Mason , Helen Wheeler , Olivier L. Chinot , Sanjeev Gill , Matthew Grif , Leland Rogers , Walter Taal , Roberta Ruda , Michael Weller , Catherine McBain , Myra E. van Linde , Kenneth Aldape , Robert B. Jenkins , Johan M. Kros , Pieter Wesseling , Andreas von Deimling , Youri Hoogstrate , Iris de Heer , Peggy N. Atmodimedjo , Hendrikus J. Dubbink , Rutger W. W. Brouwer , Wilfred F. J. van IJcken , Kin Jip Cheung , Vassilis Golfinopoulos , Brigitta G. Baumert , Thierry Gorlia , Pim J. French , Martin J. van den Bent Clinical Cancer Research（2022）
关键词
Radiotherapy, Glioblastoma, Intratumor Heterogeneity
AI 理解论文
溯源树
样例
